Valentina Dilda
Former Director of Clinical Innovation and Transformation
Bio:
Dr. Valentina Dilda is the former Director of Clinical Innovation and Transformation at Cerevel Therapeutics, a biopharmaceutical company focused on developing new therapies to treat Neurological and Neuropsychiatric Disorders, acquired by AbbVie in 2024. As part of the Data Science and Innovation Team, she identified novel approaches to leverage AI, data, and technology to improve efficiencies cross-functionally. Before joining Cerevel, she led the integration of digital solutions in clinical trials at Novartis within the Division of US Clinical Development and Medical Affairs. Valentina received her Ph.D. in Cognitive and Neural Science from the University of Utah, followed by a Postdoc in Neurology at Mount Sinai at the Human Aerospace Lab (NASA-NSBRI funded).